Monitoring carbon dioxide levels in patients on VA-ECMO
Official title: Validation of Continuously Determined Transcutaneous Carbon Dioxide Partial Pressures in Patients Supported With Veno-arterial Extracorporeal Membrane Oxygenation
Run by Medical University of Vienna · NCT04445909 · Data updated 2026-11-12
This study tests if a new way of measuring carbon dioxide levels on the skin can give better results than regular blood tests for patients on VA-ECMO.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Medical University of Vienna Academic / other |
| Locations | 1 site (Vienna) |
| Status | Recruiting |
| Started | November 18, 2019 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT04445909 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults with low cardiac output requiring VA-ECMO support.
✕Probably not a fit
Patients under 18 years old will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of continuous transcutaneous carbon dioxide monitoring in patients receiving veno-arterial extracorporeal membrane oxygenation (VA-ECMO). It aims to compare non-invasive transcutaneous carbon dioxide measurements with traditional blood gas analysis to improve monitoring accuracy. Participants will have their carbon dioxide levels measured simultaneously through various methods over a four-hour observation period. The study also records additional physiological parameters to assess the overall condition of the patients.
Why it matters
Potential benefit: If successful, this study could enhance the monitoring of carbon dioxide levels in VA-ECMO patients, potentially improving patient outcomes by preventing harmful fluctuations.
How similar studies have gone: While this approach is innovative, similar studies have not been widely reported, indicating a novel exploration in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Low cardiac output requiring VA-ECMO support. Exclusion Criteria: * Age \< 18 years
Where it's running
-
Medical University of Vienna
Vienna, Austria Recruiting
Study contacts
- Principal investigator: Martin Dworschak, MD, MBA — Medical University of Vienna
- Study coordinator: Martin Dworschak, MD, MBA
- Email: martin.dworschak@meduniwien.ac.at
- Phone: +43-1-40400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Moderate CO2 increase during anesthesia to boost collateral flow in clot removal for acute anterior stroke
This study will test whether slightly higher blood carbon dioxide during anesthesia improves collateral blood flow and protects the brain in people having mechanical thrombectomy for anterior large-vessel ischemic stroke.
-
Steatotic Liver Disease in Austria: A Long-Term Registry and Biobank
This registry will follow adults with suspected or confirmed steatotic liver disease in Austria to learn about how the disease progresses and which non-invasive tests best predict outcomes.
-
Kidney fibrosis imaging with Ga-68 FAPI PET/CT in CKD
This study tests whether a Ga-68 FAPI PET/CT scan can reflect how much fibrosis is in the kidneys of people with chronic kidney disease.
-
Myo-Inositol for Glycemic Control in Gestational Diabetes
This study tests whether taking myo-inositol with folic acid can improve blood sugar control and reduce inflammation in pregnant people with gestational diabetes.
-
BAL balance: ARDS through lung lavage and imaging to find different ARDS types
This study tests how bronchoalveolar lavage fluid and chest CT imaging can reveal different ARDS subtypes in adults with ARDS or severe pneumonia in the ICU.
-
Does a CDT level at ICU admission predict short-term outcomes in critically ill adults?
This study tests whether high carbohydrate-deficient transferrin levels at ICU admission can predict worse short-term outcomes for adults with critical illness from emergency department admissions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.